Post-Traumatic Stress Disorder (PTSD) Therapeutics Pipeline Projects Immense Growth Ahead: P&S Market Research

NEW YORK, April 06, 2018 -- According to a new research report titled “Post-Traumatic Stress Disorder Therapeutics Pipeline Analysis, 2017” published by P&S Market Research, PTSD currently exhibits a strong pipeline with 23 drug candidates.

Request for Sample Copy of this Research Report: https://www.psmarketresearch.com/market-analysis/ptsd-therapeutics-pipeline-analysis/report-sample

The study analysed that the PTSD pipeline comprises of 23 drug candidates in different stages of development. PTSD is a neurological disorder that develops in people who have experienced a scary or a dangerous event. PTSD can occur in a person at any age. According to the National Center of PTSD, around seven to eight out of 100 individuals experience PTSD at some point in their lives. Most of the people recover from traumatic situation naturally, but those who continue to experience problems are diagnosed with PTSD. People with PTSD are used to feel frightened even when they are not in a dangerous situation. PTSD generally occurs more often in women than men. Various collaboration between educational institutes, associations, and pharma companies are driving the therapeutic pipeline of PTSD.

Many patents have been received during the development of drug candidates for the treatment of PTSD. In May 2017, Tonix reported the issuance of patent 9 636 408 by the United States Patent and Trademark Office titled “Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride,” covering the composition and manufacture of its proprietary sublingual formulation of very low dose cyclobenzaprine.

Browse Full Report with detailed TOC on “Post-Traumatic Stress Disorder Therapeutics Pipeline Analysis” at: https://www.psmarketresearch.com/market-analysis/ptsd-therapeutics-pipeline-analysis

Some of the key players developing drugs for the treatment of PTSD include India Globalization Capital, Inc., Therapade Technologies LLC, Axim Biotechnologies, Inc. and others.

More Reports Published by P&S Market Research

Ulcerative Colitis Therapeutics Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/ulcerative-colitis-pipeline-analysis

Ewing Sarcoma Therapeutics Pipeline Analysis - https://www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: [email protected]

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook